MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
VTGN - VistaGen Therapeutics Inc
$2.34
-0.15(-6.02%)8:59:56 PM 2/24/2021
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing medicines to treat diseases and disorders of the central nervous system. It focuses on depressive and social anxiety disorders. The company's lead product candidate is AV-101 that is in Phase II clinical trial for the treatment of chronic neuropathic pain, epilepsy, major depressive disorder (MDD), parkinson's disease levodopa-induced dyskinesia, and suicidal ideation; PH94B, a neuroactive nasal spray that is in Phase III clinical trial for social anxiety disorder (SAD), and Phase IIa clinical trial for generalized anxiety disorder; and PH10, a neuroactive nasal spray that is in Phase IIb clinical trial for MDD. It has licensing, sublicensing, and collaboration agreements with Pherin Pharmaceuticals, Inc.; BlueRock Therapeutics, LP; and Cato Research Ltd. The company also has a strategic licensing and collaboration agreement with EverInsight Therapeutics Inc. for the clinical development and commercialization of PH94B for multiple anxiety-related disorders in Greater China, South Korea, and Southeast Asia. VistaGen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
MarketCap350M
PE Ratio
PEG Ratio
P/B35.6
P/S (ttm)842.0
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %4%
Held by Institutions %8%
1 Day Vol Adjusted Return-0.4
1 Month Vol Adjusted Return1.3
3 Month Vol Adjusted Return28.0
6 Month Vol Adjusted Return28.4
20 Days SMA Price ZScore1.1
50 Days SMA Price ZScore1.0
12 -26 Days PPO6.7
1 Month Average Short Volume Ratio42.7
1 Day Volume Change ZScore0.1
1 Month Daily Vol8.8
Related Topics
leak data

Related Topics

Peers

Related Peers

Stock news